PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
3.85%
Net income growth similar to AVGO's 4.08%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
-0.82%
Both reduce yoy D&A, with AVGO at -11.28%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
136.36%
Well above AVGO's 67.54% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
45.24%
SBC growth while AVGO is negative at -1.11%. John Neff would see competitor possibly controlling share issuance more tightly.
-179.62%
Both reduce yoy usage, with AVGO at -167.94%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-672.73%
Both yoy AR lines negative, with AVGO at -163.17%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-44.44%
Both reduce yoy inventory, with AVGO at -23.88%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
2200.00%
AP growth well above AVGO's 119.13%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
-204.79%
Both reduce yoy usage, with AVGO at -176.47%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
97.80%
Well above AVGO's 93.18%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-12.94%
Both yoy CFO lines are negative, with AVGO at -7.02%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-45.28%
Both yoy lines negative, with AVGO at -11.76%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
-100.00%
Negative yoy acquisition while AVGO stands at 96.33%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-18.33%
Negative yoy purchasing while AVGO stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
26.02%
Liquidation growth of 26.02% while AVGO is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
91.81%
We have some outflow growth while AVGO is negative at -500.00%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-11.35%
Both yoy lines negative, with AVGO at -22.00%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-10.00%
Both yoy lines negative, with AVGO at -206.67%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
71.93%
We slightly raise equity while AVGO is negative at -65.69%. John Neff sees competitor possibly preserving share count or buying back shares.
-566.67%
Both yoy lines negative, with AVGO at -21.62%. Martin Whitman would see an overall reduced environment for buybacks in the niche or cyclical factor driving capital usage.